Prevalence of Acinetobacter baumannii and Pseudomonas aeruginosa isolates resistant to imipenem by production of metallo-β-lactamase;Prévalence des souches d'Acinetobacter baumannii et de Pseudomonas aeruginosa résistantes à l'imipénème par production de métallo-β-lactamases

Medecine et Maladies Infectieuses

Volumn 36, Issue 7, 2006, Pages 386-389

  Ait el kadi, M ^a   Aghrouch, M ^a   Seffar, M ^a   El harti, J ^b   Bouklouze, A ^b   Cherrah, Y ^b   Souly, K ^a   Zouhdi, M ^a  

^a IBN SINA HOSPITAL   (Morocco)

^b MOHAMMED V UNIVERSITY   (Morocco)

Author keywords

Acinetobacter baumannii; Imipenem; metallo lactamase; Pseudomonas aeruginosa; Resistance

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ENZYME; EDETIC ACID; IMIPENEM; METALLO BETA LACTAMASE; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ACINETOBACTER BAUMANNII; ALKALINITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DISINFECTION; ENZYME ANALYSIS; ENZYME SYNTHESIS; GRAM NEGATIVE BACTERIUM; HOSPITAL LABORATORY; MICROBIAL SENSITIVITY TEST; MOROCCO; NONHUMAN; PSEUDOMONAS AERUGINOSA; SEROEPIDEMIOLOGY; SEROPREVALENCE; STRAIN IDENTIFICATION; ACINETOBACTER; DRUG EFFECT; ENZYMOLOGY; ISOLATION AND PURIFICATION; METABOLISM;

ACINETOBACTER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; IMIPENEM; PSEUDOMONAS AERUGINOSA;

EID: 33746794710     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2006.05.003     Document Type: Article

References (9)

1. Galleni M., Lamotte-Brasseur J., Rossolini G.M., Spencer J., Dideberg O., and Frère J.M. Metallo-β-lactamase working group. Standard numbering scheme for class B β-lactamases. Antimicrob. Agents Chemother. 45 (2001) 660-663
2. Yong D., Lee K., Yum J.H., Shin H.B., Rossolini G.M., and Chong Y. Imipenem-EDTA disk method for differentiation of metallo-β-lactamase producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 40 (2002) 3798-3801
3. Nordmann P. Acinetobacter baumannii, le pathogène nosocomial par excellence. Pathol. Biol. 52 (2004) 301-303
4. Zavascki A.P., Cruz R.P., and Goldani L.Z. Risk factors for imipenem-resistant Pseudomonas aeruginosa : a comparative analysis of two case-control studies in hospitalized patients. J. Hosp. Infect. 59 (2005) 96-101
5. Watanabe M., Lyobe S., Inoue M., and Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 35 (1991) 147-151
6. Altoparlak U., Aktas F., Celebi D., Ozkurt Z., and Akcay M.N. Prevalence of metallo-β-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii isolated from burn wounds and in vitro activities of antibiotic combinations against these isolates. Burns 31 (2005) 707-710
7. Sader H.S., Castanheira M., Mendes R.E., Toleman M., Walsh T.R., and Jones R.N. Dissemination and diversity of metallo-β-lactamase in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Int. J. Antimicrob. Agents 25 (2005) 57-61
8. Lee K., Lee W.G., Uh Y., Ha G.Y., Cho J., and Chong Y. Korean nation wide surveillance of antimicrobial resistance group. VIM- and IMP-type metallo-β-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals. Emerg. Infect. Dis. 9 (2003) 868-871
9. Luzzaro F., Endimiani A., Docquier J.D., Mugnaioli C., Bonsignori M., Amicosante G., et al. Prevalence and characterization of metallo-β-lactamases in clinical isolates of Pseudomonas aeruginosa. Diagn. Microbiol. Infect. Dis. 48 (2004) 131-135